武田製藥 TAK 深滬

等待開盤 02-06 09:30:00 美东时间

17.80

+0.060

+0.34%

華盛通

立即下載

最高17.94
今開17.82
成交量 267.99万股
最低 17.755
昨收 17.74
總市值 566.40亿
52周最高 17.94
市盈率 ^靜 80.73
換手率 0.08%
52周最低 12.99
委比 31.51%
總股本 31.82亿
歷史最高 17.94
量比 0.62
振幅 1.04%
歷史最低 8.7904
每手 1
風險率 0.84%

個股概要

財務分析

公司資料

分紅派息

分時圖
日k
周k
月k

相關新聞

Alvotech higher on positive data backing biosimilar to Takeda’s Entyvio

Alvotech (ALVO) shares spiked ~3% in the premarket on Thursday after the Luxembourg-based biotech succeeded in a study designed to evaluate AVT80, its proposed biosimilar to Entyvio, a bowel disease t...

02-05 21:15
Takeda Updates FY2025 Outlook, Revises Core Revenue To Low-Single-Digit Decline While Maintaining Low-Single-Digit Declines In Core Operating Profit And Core EPS

FY2025 OutlookUpdating Full Year Management Guidance for Revenue and ForecastsTakeda has updated its full year Management Guidance for Revenue primarily due to VYVANSE and raised full year forecasts to reflect cost

01-29 15:05
Takeda Pharmaceutical Q3 Adj. EPS $0.47 Misses $0.55 Estimate, Sales $7.600B Miss $8.530B Estimate

Takeda Pharmaceutical (NYSE:TAK) reported quarterly earnings of $0.47 per share which missed the analyst consensus estimate of $0.55 by 13.64 percent. This is a 7.95 percent increase over earnings of $0.44 per share from

01-29 14:58
日经指数上涨0.6% 受金融股和电子股带动

　　日本日经指数上涨0.6%，报53，698.24点，金融股和电子股的上涨帮助抵消了零售股和科技股的下跌影响。日本邮政银行上涨3.3%，铠侠上涨6.0%，而永旺...

01-29 08:26
Takeda Pharmaceutical Q3 Earnings Preview

Takeda Pharmaceutical (TAK) is scheduled to announce Q3 earnings results on Thursday, January 29th, before market open. Analysts on average of GAAP EPS of JPY 43.14 on revenue of JPY 1.193T. More on T...

01-29 00:20
跨国药企扫货中国创新药谁是首席买家

经济观察报记者张英 2026年摩根大通医疗健康大会（JPM）已结束一周，多家跨国公司在会上明确表达对中国资产的兴趣。多位受访者对经济观察报表示，其所在药企...

01-25 10:22
Takeda Announces U.S. Availability Of GAMMAGARD LIQUID ERC To Treat Primary Immunodeficiency

Takeda ((

01-22 20:46
武田制药(TAK.US)1类新药“奥博雷通片”在中国申报上市

武田制药(TAK.US)1类新药“奥博雷通片”在中国申报上市。

01-16 15:32
15天9起合作，狂飙60亿美元！2026AI制药开门红，礼来、英伟达、赛诺菲重金押注！

2026年，AI制药开门红！仅仅过了半个月，AI药物研发合作密集发布。据智药局统计，15天内跨国药企AI制药相关合作已经超过9起，总额超60亿美元。 ...

01-15 18:38
日经225指数继续走高，首次升破54000点

1月14日，日经225指数继续走高，首次升破54000点，创下盘中新高。据同花顺数据，截止发稿，日经225指数报54140，涨约0.72%。与此同时，日经指数...

01-14 08:43

派息除權日	每股總股息	派息日期
2025-09-30	0.32
2025-03-31	0.32
2024-09-30	0.33	2024-09-30
2024-03-27	0.30	2024-03-27
2023-09-28	0.26	2023-12-11
2023-03-30	0.27	2023-07-10
2022-09-29	0.30	2022-09-29
2022-03-30	0.36	2022-03-30
2021-09-29	0.39	2021-09-29
2021-03-30	0.40	2021-03-30
2020-09-29	0.37	2020-09-29
2020-03-30	0.32	2020-07-06
2019-09-27	0.32	2019-12-12
2019-03-27	0.36	2019-06-28
2018-09-26	0.30	2018-12-01
2018-03-27	0.30	2018-07-09
2017-09-27	0.31	2017-12-01
2017-03-29	0.36	2017-07-10
2016-09-28	0.29	2016-12-12
2016-03-29	0.32	2016-07-11
2015-09-28	0.28	2015-12-11
2015-03-27	0.33	2015-06-01
2014-09-26	0.29	2014-12-11
2014-03-27	0.37	2014-06-30
2013-09-26	0.43	2013-12-01
2013-03-27	0.45	2013-06-01
2012-09-26	0.55	2012-09-26
2012-03-28	0.50	2012-07-09
2011-09-28	0.51	2011-12-12
2011-03-29	0.49	2011-07-07
2010-09-27	0.50	2010-12-13
2010-03-29	0.45	2010-07-14
2009-09-25	0.46	2009-12-15
2009-03-26	0.42	2009-07-14
2008-09-25	0.41	2008-12-16
2008-03-26	0.36	2008-03-26

公司名稱	Takeda Pharmaceutical Co., Ltd.
行業分類	Pharmaceuticals: Major
業務描述	Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.

武田製藥 TAK 深 滬

17.80

個股概要

財務分析

公司資料

相關新聞

分紅派息

相關新聞

公司簡介

武田製藥 TAK 深滬